Gilead Sciences Investor

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.

Acquisitions Number: Made Acquisitions
Headquarters: Foster City, California, United States
Funding Status: IPO
Employee Number: 10001+
Estimated Revenue: $1B to $10B
Last Funding Type: Seed
Number Of Exists: 10
Technology: Others
Last Funding Date: 1988-01-01
Investors Number: 39
Founded Date: 1987-06-22
Industry: Biopharma, Biotechnology, Commercial, Health Care, Manufacturing, Pharmaceutical